Experts reveal their top picks for gastrointestinal oncology presentations from the 2026 ASCO Annual Meeting.
Related to this article
The FDA approved SimpleScreen CRC as a screening option for colorectal cancer in adults 45 years of age and older at average risk for the disease.
Advertisement
Advertisement
Trending on OncLive
1
Phase 1 Data Set the Stage for Further Exploration of Cevostamab in R/R Myeloma
2
Dr Mulvey on Real-World Treatment Discontinuation Data for First-Line BTK Inhibitors in CLL
3
Dr Cohen on Phase 1 Efficacy Data for Cevostamab in R/R Myeloma
4
Docirbrutinib Yields High Response Rates in MCL and CLL
5